<p>在比利时，<strong>百威英博</strong>（EBR:ABI）的市盈率为 16.5 倍，似乎并不值得一提，因为该国的中位市盈率大约为 16 倍。不过，简单忽视市盈率而不加解释并不明智，因为投资者可能会忽略一个独特的机会或犯下一个代价高昂的错误。</p>
<p>人工智能即将改变医疗保健。这 20 只股票正在从早期诊断到药物发现等各个方面进行探索。最棒的是——它们的市值都在 100 亿美元以下——现在仍然有机会提前布局。</p>
<p>最近一段时间对百威英博来说是有利的，因为其收益增长速度超过了大多数其他公司。一个可能性是，市盈率适中是因为投资者认为这种强劲的收益表现可能即将减弱。如果你喜欢这家公司，你会希望这种情况不会发生，这样你就可以在它还不太受欢迎时买入一些股票。</p>
<p>查看我们对百威英博的最新分析</p>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/745257-pe-multiple-vs-industry-1-dark-2/1757318273399?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/745257-pe-multiple-vs-industry-1-dark-2/1757318273399"/></p>
<p>ENXTBR:ABI 市盈率与行业比较 2025 年 9 月 8 日</p>
<p>如果你想了解分析师对未来的预测，可以查看我们关于百威英博的 <strong>免费</strong> 报告。</p>
<h2>增长是否与市盈率匹配？</h2>
<p>有一个内在的假设，即像百威英博这样的公司，其市盈率应该与市场相匹配，才被认为是合理的。</p>
<p>首先回顾一下，我们看到该公司去年的每股收益增长了令人印象深刻的 21%。最近三年期间，每股收益整体增长了 88%，得益于其短期表现。因此，我们可以确认该公司在这段时间内成功地实现了收益增长。</p>
<p>展望未来，分析师预计接下来的三年每年将实现 13% 的增长。同时，市场的其他部分预计每年将扩展 11%，这并没有实质性差异。</p>
<p>根据这些信息，我们可以看到为什么百威英博的市盈率与市场相对接近。显然，股东们愿意在公司保持低调的同时继续持有股票。</p>
<h2>关键要点</h2>
<p>仅仅使用市盈率来判断是否应该出售你的股票并不明智，然而它可以作为公司未来前景的实用指南。</p>
<p>我们已经确定，百威英博的适中市盈率是基于其预测增长与更广泛市场一致的预期。在这一阶段，投资者认为收益改善或恶化的潜力不足以证明高或低市盈率的合理性。在这种情况下，很难看到股价在短期内有强劲的波动。</p>
<p>始终需要考虑投资风险的潜在威胁。我们已经发现了 <strong>百威英博的 1 个警告信号</strong>，理解这一点应该成为你投资过程的一部分。</p>
<p>当然，<strong>你也可能找到比百威英博更好的股票</strong>。因此，你可能希望查看这份 <strong>免费</strong> 的其他公司集合，这些公司具有合理的市盈率并且收益增长强劲。</p>

百威英博

<p>百威英博（Anheuser-Busch InBev SA/NV，EBR:ABI）的市盈率为 16.5 倍，略高于比利时的中位数 16 倍。尽管去年强劲的盈利增长达 21%，并且在三年内上涨了 88%，投资者可能对未来的表现持谨慎态度。分析师预测未来三年每股收益（EPS）将增长 13%，与市场预期一致。目前的市盈率反映了这一前景，暗示价格大幅波动的潜力有限。投资者在考虑其他投资机会时，应注意风险，包括一个已识别的警示信号</p>

<p>There wouldn't be many who think <strong>Anheuser-Busch InBev SA/NV's</strong> (EBR:ABI) price-to-earnings (or &#34;P/E&#34;) ratio of 16.5x is worth a mention when the median P/E in Belgium is similar at about 16x. Although, it's not wise to simply ignore the P/E without explanation as investors may be disregarding a distinct opportunity or a costly mistake.</p>
<div class="lb-trans"><p>在比利时，<strong>百威英博</strong>（EBR:ABI）的市盈率为 16.5 倍，似乎并不值得一提，因为该国的中位市盈率大约为 16 倍。不过，简单忽视市盈率而不加解释并不明智，因为投资者可能会忽略一个独特的机会或犯下一个代价高昂的错误。</p>
</div><p>AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.</p>
<div class="lb-trans"><p>人工智能即将改变医疗保健。这 20 只股票正在从早期诊断到药物发现等各个方面进行探索。最棒的是——它们的市值都在 100 亿美元以下——现在仍然有机会提前布局。</p>
</div><p>Recent times have been advantageous for Anheuser-Busch InBev as its earnings have been rising faster than most other companies. One possibility is that the P/E is moderate because investors think this strong earnings performance might be about to tail off. If you like the company, you'd be hoping this isn't the case so that you could potentially pick up some stock while it's not quite in favour.</p>
<div class="lb-trans"><p>最近一段时间对百威英博来说是有利的，因为其收益增长速度超过了大多数其他公司。一个可能性是，市盈率适中是因为投资者认为这种强劲的收益表现可能即将减弱。如果你喜欢这家公司，你会希望这种情况不会发生，这样你就可以在它还不太受欢迎时买入一些股票。</p>
</div><p>View our latest analysis for Anheuser-Busch InBev</p>
<div class="lb-trans"><p>查看我们对百威英博的最新分析</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/745257-pe-multiple-vs-industry-1-dark-2/1757318273399" alt="" original-src="https://images.simplywall.st/asset/chart/745257-pe-multiple-vs-industry-1-dark-2/1757318273399"/></p>
<p>ENXTBR:ABI Price to Earnings Ratio vs Industry September 8th 2025</p>
<div class="lb-trans"><p>ENXTBR:ABI 市盈率与行业比较 2025 年 9 月 8 日</p>
</div><p>If you'd like to see what analysts are forecasting going forward, you should check out our <strong>free</strong> report on Anheuser-Busch InBev.</p>
<div class="lb-trans"><p>如果你想了解分析师对未来的预测，可以查看我们关于百威英博的 <strong>免费</strong> 报告。</p>
</div><h2>Does Growth Match The P/E?</h2>
<div class="lb-trans"><h2>增长是否与市盈率匹配？</h2>
</div><p>There's an inherent assumption that a company should be matching the market for P/E ratios like Anheuser-Busch InBev's to be considered reasonable.</p>
<div class="lb-trans"><p>有一个内在的假设，即像百威英博这样的公司，其市盈率应该与市场相匹配，才被认为是合理的。</p>
</div><p>Taking a look back first, we see that the company grew earnings per share by an impressive 21% last year. The latest three year period has also seen an excellent 88% overall rise in EPS, aided by its short-term performance. So we can start by confirming that the company has done a great job of growing earnings over that time.</p>
<div class="lb-trans"><p>首先回顾一下，我们看到该公司去年的每股收益增长了令人印象深刻的 21%。最近三年期间，每股收益整体增长了 88%，得益于其短期表现。因此，我们可以确认该公司在这段时间内成功地实现了收益增长。</p>
</div><p>Turning to the outlook, the next three years should generate growth of 13% per year as estimated by the analysts watching the company. Meanwhile, the rest of the market is forecast to expand by 11% per year, which is not materially different.</p>
<div class="lb-trans"><p>展望未来，分析师预计接下来的三年每年将实现 13% 的增长。同时，市场的其他部分预计每年将扩展 11%，这并没有实质性差异。</p>
</div><p>With this information, we can see why Anheuser-Busch InBev is trading at a fairly similar P/E to the market. Apparently shareholders are comfortable to simply hold on while the company is keeping a low profile.</p>
<div class="lb-trans"><p>根据这些信息，我们可以看到为什么百威英博的市盈率与市场相对接近。显然，股东们愿意在公司保持低调的同时继续持有股票。</p>
</div><h2>The Key Takeaway</h2>
<div class="lb-trans"><h2>关键要点</h2>
</div><p>Using the price-to-earnings ratio alone to determine if you should sell your stock isn't sensible, however it can be a practical guide to the company's future prospects.</p>
<div class="lb-trans"><p>仅仅使用市盈率来判断是否应该出售你的股票并不明智，然而它可以作为公司未来前景的实用指南。</p>
</div><p>We've established that Anheuser-Busch InBev maintains its moderate P/E off the back of its forecast growth being in line with the wider market, as expected. At this stage investors feel the potential for an improvement or deterioration in earnings isn't great enough to justify a high or low P/E ratio. It's hard to see the share price moving strongly in either direction in the near future under these circumstances.</p>
<div class="lb-trans"><p>我们已经确定，百威英博的适中市盈率是基于其预测增长与更广泛市场一致的预期。在这一阶段，投资者认为收益改善或恶化的潜力不足以证明高或低市盈率的合理性。在这种情况下，很难看到股价在短期内有强劲的波动。</p>
</div><p>It's always necessary to consider the ever-present spectre of investment risk. We've identified <strong>1 warning sign with Anheuser-Busch InBev</strong>, and understanding should be part of your investment process.</p>
<div class="lb-trans"><p>始终需要考虑投资风险的潜在威胁。我们已经发现了 <strong>百威英博的 1 个警告信号</strong>，理解这一点应该成为你投资过程的一部分。</p>
</div><p>Of course, <strong>you might also be able to find a better stock than Anheuser-Busch InBev</strong>. So you may wish to see this <strong>free</strong> collection of other companies that have reasonable P/E ratios and have grown earnings strongly.</p>
<div class="lb-trans"><p>当然，<strong>你也可能找到比百威英博更好的股票</strong>。因此，你可能希望查看这份 <strong>免费</strong> 的其他公司集合，这些公司具有合理的市盈率并且收益增长强劲。</p>
</div>

对百威英博 SA/NV（EBR:ABI）盈利感兴趣的投资者